Literature DB >> 12366395

Roles and regulation of glutamate transporters in the central nervous system.

R D O'Shea1.   

Abstract

1. Glutamate transporters (also known as excitatory amino acid transporters or EAAT) are solely responsible for the removal of the excitatory neurotransmitter l-glutamate (Glu) from the extracellular space and, thus, permit normal transmission, as well as preventing cell death due to the excessive activation of Glu receptors. 2. Five subtypes of glutamate transporter (EAAT1-5) exist, possessing distinct pharmacology, cellular localization and modulatory mechanisms. 3. Experimental inhibition of EAAT activity in vitro and in vivo results in increased extracellular concentrations of Glu and in neuronal death via excitotoxicity, highlighting the importance of EAAT in normal excitatory neurotransmission. 4. Dysfunction of EAAT may contribute to the pathology of both acute neuronal injury and chronic neurodegenerative conditions, so correction of EAAT function under these conditions may provide a valuable therapeutic strategy. 5. The present review describes basic pharmacological studies that allow new insights into EAAT function and suggest possible strategies for the therapeutic modulation of EAAT.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12366395     DOI: 10.1046/j.1440-1681.2002.03770.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  31 in total

1.  Differential effects of Na+-K+ ATPase blockade on cortical layer V neurons.

Authors:  Trent R Anderson; John R Huguenard; David A Prince
Journal:  J Physiol       Date:  2010-09-06       Impact factor: 5.182

2.  The effects of estradiol on estrogen receptor and glutamate transporter expression in organotypic hippocampal cultures exposed to oxygen--glucose deprivation.

Authors:  Helena Cimarosti; Ross D O'Shea; Nicole M Jones; Ana Paula Horn; Fabrício Simão; Lauren L Zamin; Melissa Nassif; Rudimar Frozza; Carlos Alexandre Netto; Philip M Beart; Christianne Salbego
Journal:  Neurochem Res       Date:  2006-05-09       Impact factor: 3.996

3.  Regulation of glutamate transporters in astrocytes: evidence for a relationship between transporter expression and astrocytic phenotype.

Authors:  Chrissandra J Zagami; Ross D O'Shea; Chew L Lau; Surindar S Cheema; Philip M Beart
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

Review 4.  Overview of glutamatergic neurotransmission in the nervous system.

Authors:  Mark J Niciu; Benjamin Kelmendi; Gerard Sanacora
Journal:  Pharmacol Biochem Behav       Date:  2011-08-26       Impact factor: 3.533

Review 5.  GLAST But Not Least--Distribution, Function, Genetics and Epigenetics of L-Glutamate Transport in Brain--Focus on GLAST/EAAT1.

Authors:  Omar Šerý; Nilufa Sultana; Mohammed Abul Kashem; David V Pow; Vladimir J Balcar
Journal:  Neurochem Res       Date:  2015-05-14       Impact factor: 3.996

6.  Localization of excitatory amino acid transporters EAAT1 and EAAT2 in human postmortem cortex: a light and electron microscopic study.

Authors:  R C Roberts; J K Roche; R E McCullumsmith
Journal:  Neuroscience       Date:  2014-07-24       Impact factor: 3.590

7.  Synthetic cathinone MDPV downregulates glutamate transporter subtype I (GLT-1) and produces rewarding and locomotor-activating effects that are reduced by a GLT-1 activator.

Authors:  Ryan A Gregg; Callum Hicks; Sunil U Nayak; Christopher S Tallarida; Paul Nucero; Garry R Smith; Allen B Reitz; Scott M Rawls
Journal:  Neuropharmacology       Date:  2016-04-13       Impact factor: 5.250

Review 8.  Riluzole in the treatment of mood and anxiety disorders.

Authors:  Christopher Pittenger; Vladimir Coric; Mounira Banasr; Michael Bloch; John H Krystal; Gerard Sanacora
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

9.  Vesicular glutamate transporter 2 is expressed in different nerve fibre populations that selectively contact pulmonary neuroepithelial bodies.

Authors:  Inge Brouns; Isabel Pintelon; Jeroen Van Genechten; Ian De Proost; Jean-Pierre Timmermans; Dirk Adriaensen
Journal:  Histochem Cell Biol       Date:  2003-12-16       Impact factor: 4.304

10.  Transcriptome analysis in a rat model of L-DOPA-induced dyskinesia.

Authors:  Christine Konradi; Jenny E Westin; Manolo Carta; Molly E Eaton; Katarzyna Kuter; Andrzej Dekundy; Martin Lundblad; M Angela Cenci
Journal:  Neurobiol Dis       Date:  2004-11       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.